SCHEMBL19973595

SCHEMBL19973595

N#Cc1cccc(NC(=O)c2cccc3c2OCC[C@@H]3NC(=O)O)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.53
GRM5 P41594 1/20 0.45
P2RX1 P51575 1/20 0.44
MAPK14 Q16539 1/20 0.43
KMT2A Q03164 2/20 0.43
EGLN1 Q9GZT9 1/20 0.42
TSHR P16473 1/20 0.42
OPRM1 P35372 1/20 0.42
OPRD1 P41143 1/20 0.42
ALDH1A1 P00352 3/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
NR1H4 Q96RI1 1/20 0.42
POLB P06746 1/20 0.42
GRM4 Q14833 1/20 0.42
RXFP1 Q9HBX9 2/20 0.41
MEN1 O00255 1/20 0.40
MAPT P10636 1/20 0.40
NPC1 O15118 1/20 0.40
NFKB1 P19838 1/20 0.40
RAB9A P51151 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19973597 1.00 HTT (0.53) HTTGRM5P2RX1MAPK14KMT2A
SCHEMBL21189489 0.89 HTT (0.47) HTTGRM5P2RX1MAPK14KMT2A
SCHEMBL19973910 0.86 HPGD (0.43) HTTKMT2AALDH1A1MEN1
SCHEMBL19973908 0.86 HPGD (0.43) HTTKMT2AALDH1A1MEN1
SCHEMBL19973497 0.85 KMT2A (0.48) GRM5P2RX1KMT2ATSHRALDH1A1
SCHEMBL19973498 0.85 KMT2A (0.48) GRM5P2RX1KMT2ATSHRALDH1A1
SCHEMBL19973421 0.82 RXFP1 (0.53) P2RX1RXFP1MAPTSMN1; SMN2
SCHEMBL19973422 0.82 RXFP1 (0.53) P2RX1RXFP1MAPTSMN1; SMN2
SCHEMBL19973433 0.82 TP53 (0.46) HTTKMT2AALDH1A1L3MBTL1MEN1
SCHEMBL19973586 0.82 TP53 (0.46) HTTKMT2AALDH1A1L3MBTL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11001564-B2 Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same ARBUTUS BIOPHARMA CORPORATION (CA) 2021-05-11 US claimed
US-20190225593-A1 SUBSTITUTED CHROMANE-8-CARBOXAMIDE COMPOUNDS AND ANALOGUES THEREOF, AND METHODS USING SAME ARBUTUS BIOPHARMA CORP (CA) 2019-07-25 US claimed
WO-2018052967-A1 SUBSTITUTED CHROMANE-8-CARBOXAMIDE COMPOUNDS AND ANALOGUES THEREOF, AND METHODS USING SAME ARBUTUS BIOPHARMA, INC. (US) 2018-03-22 WO claimed
US-11001564-B2 Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same ARBUTUS BIOPHARMA CORPORATION (CA) 2021-05-11 US disclosed
US-20190225593-A1 SUBSTITUTED CHROMANE-8-CARBOXAMIDE COMPOUNDS AND ANALOGUES THEREOF, AND METHODS USING SAME ARBUTUS BIOPHARMA CORP (CA) 2019-07-25 US disclosed
WO-2018052967-A1 SUBSTITUTED CHROMANE-8-CARBOXAMIDE COMPOUNDS AND ANALOGUES THEREOF, AND METHODS USING SAME ARBUTUS BIOPHARMA, INC. (US) 2018-03-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190225593-A1 SUBSTITUTED CHROMANE-8-CARBOXAMIDE COMPOUNDS AND ANALOGUES THEREOF, AND METHODS USING SAME CBX8, HAVCR2, HCCS HTT 2199/4885GRM5 3087/4885P2RX1 1285/4885
US-11001564-B2 Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same CBX8, HAVCR2, HCCS HTT 2199/4885GRM5 3087/4885P2RX1 1285/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.